JINCHUAN INTL (02362) reported a profit announcement, with an expected annual comprehensive net profit attributable to shareholders of approximately 25 to 35 million US dollars, expected to change from loss to profit.
Jinchuan International (02362) announces that the Group is expected to achieve a net profit attributable to shareholders of approximately 25 million to 35 million US dollars during the reporting period in 2025. This expected turnaround from loss to profit is compared to the Group's expectation of a net loss attributable to shareholders not exceeding 5 million US dollars in the reporting period of 2024.
Jinchuan International (02362) announced that the group is expected to achieve a net profit attributable to shareholders of approximately $25 million to $35 million during the reporting period in 2025. The expected turnaround from loss to profit is compared to the expected net loss of not more than $5 million for the reporting period in 2024.
Currently, the expected net loss for the reporting period in 2024 remains consistent with the company's announcement dated March 7, 2025, entitled "Profit Warning - Decrease in Loss." The main factors leading to the expected turnaround from loss to profit in the reporting period of 2025 are mainly attributed to the increase in selling prices of the group's main products and effective cost control.
Related Articles

US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.

IMMUNOTECH-B (06978) released its annual performance report, with a net loss attributable to shareholders of 231 million yuan, an increase of 23.47% year-on-year.
US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.

IMMUNOTECH-B (06978) released its annual performance report, with a net loss attributable to shareholders of 231 million yuan, an increase of 23.47% year-on-year.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


